<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref005">
 <label>5</label>
 <mixed-citation publication-type="other">Kalorama Information. What's Trending in Monoclonal Antibodies (Markets by Structure, by Target, and by Indication)
  <ext-link ext-link-type="uri" xlink:href="https://kaloramainformation.com/product/whats-trending-in-monoclonal-antibodies-market-by-structure-chimeric-humanized-by-target-egfr-tnf-her2-cd20pd-1-other-and-by-disease-autoimmune-oncology-neurological-other/" xmlns:xlink="http://www.w3.org/1999/xlink">https://kaloramainformation.com/product/whats-trending-in-monoclonal-antibodies-market-by-structure-chimeric-humanized-by-target-egfr-tnf-her2-cd20pd-1-other-and-by-disease-autoimmune-oncology-neurological-other/</ext-link>. 2017. [cited 2020 Jan 11].
 </mixed-citation>
</ref>
